63 related articles for article (PubMed ID: 25503741)
21. Diabetes and impaired glucose tolerance prevalences in Turkish patients with impaired fasting glucose.
Tutuncuoğlu P; Saraç F; Saygili F; Ozgen AG; Yilmaz C; Tüzün M
Acta Diabetol; 2008 Sep; 45(3):151-6. PubMed ID: 18496644
[TBL] [Abstract][Full Text] [Related]
22. Expression of genes involved in lipid metabolism in men with impaired glucose tolerance: impact of insulin stimulation and weight loss.
Konings E; Corpeleijn E; Bouwman FG; Mariman EC; Blaak EE
J Nutrigenet Nutrigenomics; 2010; 3(1):9-17. PubMed ID: 20699619
[TBL] [Abstract][Full Text] [Related]
23. [Characteristics of glycemic excursion in different subtypes of impaired glucose intolerance].
Kang Y; Lu JM; Sun JF; Li CL; Wang XL; Zhang XQ; Lü ZH; Dou JT; Mu YM
Zhonghua Yi Xue Za Zhi; 2009 Mar; 89(10):669-72. PubMed ID: 19595059
[TBL] [Abstract][Full Text] [Related]
24. Defective liver disposal of free fatty acids in patients with impaired glucose tolerance.
Iozzo P; Turpeinen AK; Takala T; Oikonen V; Bergman J; Grönroos T; Ferrannini E; Nuutila P; Knuuti J
J Clin Endocrinol Metab; 2004 Jul; 89(7):3496-502. PubMed ID: 15240637
[TBL] [Abstract][Full Text] [Related]
25. Sex differences in myocardial oxygen and glucose metabolism.
Peterson LR; Soto PF; Herrero P; Schechtman KB; Dence C; Gropler RJ
J Nucl Cardiol; 2007 Jul; 14(4):573-81. PubMed ID: 17679067
[TBL] [Abstract][Full Text] [Related]
26. [The influence of physical training on metabolic indices in men with myocardial infarction and impaired glucose tolerance].
Stochmal A; Jasiak-Tyrkalska B; Stochmal E; Huszno B; Kawecka-Jaszcz K
Przegl Lek; 2007; 64(6):410-5. PubMed ID: 18159849
[TBL] [Abstract][Full Text] [Related]
27. Metabolic syndrome in subjects at high risk for type 2 diabetes: the genetic, physiopathology and evolution of type 2 diabetes (GENFIEV) study.
Bianchi C; Miccoli R; Bonadonna RC; Giorgino F; Frontoni S; Faloia E; Marchesini G; Dolci MA; Alviggi L; Gnasso A; Consoli A; Cavalot F; Cavallo MG; Leonetti F; Giaccari A; Del Prato S;
Nutr Metab Cardiovasc Dis; 2011 Sep; 21(9):699-705. PubMed ID: 21291660
[TBL] [Abstract][Full Text] [Related]
28. Gender differences in regional fatty acid metabolism before and after meal ingestion.
Jensen MD
J Clin Invest; 1995 Nov; 96(5):2297-303. PubMed ID: 7593616
[TBL] [Abstract][Full Text] [Related]
29. Factors determining normalization of glucose intolerance in middle-aged Swedish men and women: a 8-10-year follow-up.
Alvarsson M; Hilding A; Ostenson CG
Diabet Med; 2009 Apr; 26(4):345-53. PubMed ID: 19388963
[TBL] [Abstract][Full Text] [Related]
30. Tumor necrosis factor alpha and insulin resistance in obese type 2 diabetic patients.
Miyazaki Y; Pipek R; Mandarino LJ; DeFronzo RA
Int J Obes Relat Metab Disord; 2003 Jan; 27(1):88-94. PubMed ID: 12532159
[TBL] [Abstract][Full Text] [Related]
31. Visceral adipose tissue accumulation and cardiovascular disease risk profile in postmenopausal women with impaired glucose tolerance or type 2 diabetes.
Lemieux S; Bédard A; Piché MÈ; Weisnagel SJ; Corneau L; Bergeron J
Clin Endocrinol (Oxf); 2011 Mar; 74(3):340-5. PubMed ID: 21092050
[TBL] [Abstract][Full Text] [Related]
32. Effects of sex and hormone replacement therapy use on the prevalence of isolated impaired fasting glucose and isolated impaired glucose tolerance in subjects with a family history of type 2 diabetes.
van Genugten RE; Utzschneider KM; Tong J; Gerchman F; Zraika S; Udayasankar J; Boyko EJ; Fujimoto WY; Kahn SE;
Diabetes; 2006 Dec; 55(12):3529-35. PubMed ID: 17130501
[TBL] [Abstract][Full Text] [Related]
33. Increased fetuin-A concentrations in impaired glucose tolerance with or without nonalcoholic fatty liver disease, but not impaired fasting glucose.
Ou HY; Yang YC; Wu HT; Wu JS; Lu FH; Chang CJ
J Clin Endocrinol Metab; 2012 Dec; 97(12):4717-23. PubMed ID: 23066121
[TBL] [Abstract][Full Text] [Related]
34. Seeing is believing: dietary fatty acids hurry up from the stomach to the heart of patients with impaired glucose tolerance.
Iozzo P
Diabetes; 2012 Nov; 61(11):2659-60. PubMed ID: 23093654
[No Abstract] [Full Text] [Related]
35. PET Measurements of Organ Metabolism: The Devil Is in the Details.
Shoghi KI; Gropler RJ
Diabetes; 2015 Jul; 64(7):2332-4. PubMed ID: 26106194
[No Abstract] [Full Text] [Related]
36. Selective Impairment of Glucose but Not Fatty Acid or Oxidative Metabolism in Brown Adipose Tissue of Subjects With Type 2 Diabetes.
Blondin DP; Labbé SM; Noll C; Kunach M; Phoenix S; Guérin B; Turcotte ÉE; Haman F; Richard D; Carpentier AC
Diabetes; 2015 Jul; 64(7):2388-97. PubMed ID: 25677914
[TBL] [Abstract][Full Text] [Related]
37. BAMBI elimination enhances alternative TGF-β signaling and glomerular dysfunction in diabetic mice.
Fan Y; Li X; Xiao W; Fu J; Harris RC; Lindenmeyer M; Cohen CD; Guillot N; Baron MH; Wang N; Lee K; He JC; Schlondorff D; Chuang PY
Diabetes; 2015 Jun; 64(6):2220-33. PubMed ID: 25576053
[TBL] [Abstract][Full Text] [Related]
38. Association of Organic Cation Transporter 1 With Intolerance to Metformin in Type 2 Diabetes: A GoDARTS Study.
Dujic T; Zhou K; Donnelly LA; Tavendale R; Palmer CN; Pearson ER
Diabetes; 2015 May; 64(5):1786-93. PubMed ID: 25510240
[TBL] [Abstract][Full Text] [Related]
39. Adipocyte hypertrophy associates with
Ye RZ; Montastier E; Frisch F; Noll C; Allard-Chamard H; Gévry N; Tchernof A; Carpentier AC
iScience; 2024 Jan; 27(1):108692. PubMed ID: 38226167
[TBL] [Abstract][Full Text] [Related]
40.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
